COVID-19 related immune hemolysis and thrombocytopenia

被引：22
|
作者：
Sahu, Kamal Kant [1 ]
Borogovac, Azra [2 ]
Cerny, Jan [3 ]
机构：
[1] St Vincent Hosp, Dept Internal Med, 123 Summer St, Worcester, MA 01608 USA
[2] Univ Oklahoma, Dept Med, Hlth Sci Ctr, Hematol Oncol Sect, 865 Res Pkwy, Oklahoma City, OK 73104 USA
[3] Univ Massachusetts, Mem Med Ctr, Dept Med, Div Hematol & Oncol, 55 N Lake Ave, Worcester, MA 01655 USA
来源：
JOURNAL OF MEDICAL VIROLOGY | 2021年 / 93卷 / 02期
关键词：
coronavirus; hemolysis; immunity;
D O I：
10.1002/jmv.26402
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The current pandemic due to coronavirus disease 2019 (COVID-19) has posed an unprecedented challenge for the medical communities, various countries worldwide, and their citizens. Severe acute respiratory syndrome coronavirus 2 has been studied for its various pathophysiological pathways and mechanisms through which it causes COVID-19. In this study, we discussed the immunological impact of COVID-19 on the hematological system, platelets, and red blood cells.
引用
收藏
页码：1164 / 1170
页数：7
相关论文
共 50 条
  • [1] Immune thrombocytopenia and COVID-19: Case report and review of literature
    Alonso-Beato, Ruben
    Morales-Ortega, Alejandro
    Fernandez, Francisco Javier De la Hera
    Moron, Ana Isabel Parejo
    Rios-Fernandez, Raquel
    Rubio, Jose Luis Callejas
    Centeno, Norberto Ortego
    LUPUS, 2021, 30 (09) : 1515 - 1521
  • [2] Challenges for management of immune thrombocytopenia during COVID-19 pandemic
    Sahu, Kamal Kant
    Siddiqui, Ahmad Daniyal
    Rezaei, Nima
    Cerny, Jan
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2277 - 2282
  • [3] Potential of Immune-Related Therapy in COVID-19
    Yuan, Chunjue
    Li, Ruoyun
    Liu, Guohong
    Pan, Yunbao
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [4] Immune thrombocytopenia, severe hematological consequence in a patient with COVID-19: A case report
    Badulescu, Oana-Viola
    Popescu, Diana
    Ciocoiu, Manuela
    Rezus, Ciprian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (03)
  • [5] Is hemolysis a novel therapeutic target in COVID-19?
    Ousaka, Daiki
    Nishibori, Masahiro
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Mechanism of thrombocytopenia in COVID-19 patients
    Xu, Panyang
    Zhou, Qi
    Xu, Jiancheng
    ANNALS OF HEMATOLOGY, 2020, 99 (06) : 1205 - 1208
  • [7] Thrombocytopenia in COVID-19 and vaccine-induced thrombotic thrombocytopenia
    Geronikolou, Styliani
    Pavlopoulou, Athanasia
    Mantzourani, Marina
    Chrousos, George
    Takan, Isil
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2022, 49 (03)
  • [8] Editorial: Definition of the immune parameters related to COVID-19 severity
    Tincati, Camilla
    de Vries, Rory
    Jesenak, Milos
    Marchetti, Giulia
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [9] Immune responses during COVID-19 infection
    Melenotte, Clea
    Silvin, Aymeric
    Goubet, Anne-Gaelle
    Lahmar, Imran
    Dubuisson, Agathe
    Zumla, Alimuddin
    Raoult, Didier
    Merad, Mansouria
    Gachot, Bertrand
    Henon, Clemence
    Solary, Eric
    Fontenay, Michaela
    Andre, Fabrice
    Maeurer, Markus
    Ippolito, Giuseppe
    Piacentini, Mauro
    Wang, Fu-Sheng
    Ginhoux, Florent
    Marabelle, Aurelien
    Kroemer, Guido
    Derosa, Lisa
    Zitvogel, Laurence
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [10] Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection
    Desai, Krishna
    Sridhar, Aarthi
    Matos, Jose
    Mulla, Sana
    Thirumaran, Rajesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
12345